Regulatory Affairs Strategy Meeting East Coast USA 2019

Regulatory Affairs Strategy Meeting US East Coast 2019 is organized by Proventa International and will be held on Nov 21, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America.

Coures Description:
Designed to build meaningful partnerships among business leaders worldwide, Proventa International’s Regulatory Affairs Strategy Meeting is not like most pharmaceutical regulatory affairs conferences. With all the delegates pre-qualified, you can be sure that you only meet and engage with primary decision makers of top and emerging biotech, pharma, IT and academic organizations. While regulatory affairs conferences expose you to huge pools of industry professionals with varied levels of experience and seniority, our Regulatory Affairs Strategy Meeting aims to provide insightful conversations with director-level executives.

Another feature you can’t find in regulatory affairs events is our executive roundtable discussions. Personalized for each delegate, these discussions allow of in-depth exchanges on pharmaceutical regulation updates, industry trends and strategic challenges. These 60-minute sessions also give way for anyone who wants to raise their questions or share their expertise.

Our Regulatory Affairs Strategy Meeting also lets you meet expert/s to help you strategize for short and long-term goals via our pre-scheduled one-to-one meetings. Depending on your strategic priorities, we connect you with the right professional from our vast network of pharmaceutical regulation experts in Boston and around the globe. Need help with CMC or Regulatory Operations? Contact us today so we can connect you with a subject matter expert!

Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
• Chemical Candidate Selection
• Data Package Completeness
• Risk Assessments
• Regulatory agency interaction
• Premarket approvals Labeling
• Advertising
• Clinical Evaluation
• Postmarket Surveillance
• Orphan Drug Submissions
• Facility Inspections
• Pricing and Market Authorisation Approval
• Product Life Cycle Management
• Quality review
• Clinical trial applications
• Marketing applications
• Compliance Change Control

Additional details will be posted as soon as they are available.